Pharma Focus Asia

Isolation Technology: Case Study

A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process.

The following requirements had to be met:

  • • To provide a safe barrier between the operator and the active drug substance to provide both operator and product protection
  • • System designed for multi product use for OEB5 category potent compounds
  • • Isolator designed for the automated discharge and manual heel removal, milling and dispensing of product discharge from filter drier.
  • • The system is to enable manual sampling to be achieved via the filter dryer sampling port which is integral to the discharge hatch
  • • The system is designed also to mill and pack other products introduced to the isolator via a RTP Rapid Transfer Port.
  • • System to operate in an inert atmosphere during product discharge.
  • • To enable the process plant to be Cleaned In Place


magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference